Stop Cancer at Work Campaign welcomes progress made in protecting workers from cancer and reproductive problems at workComments Off on Stop Cancer at Work Campaign welcomes progress made in protecting workers from cancer and reproductive problems at work

The Stop Cancer at Work Campaign welcomes the provisional political agreement by the European Parliament and European Council to include for the first time greater protection and reference to reprotoxic substances and hazardous medicinal products in the fourth revision of the Carcinogens and Mutagens Directive (CMD).

The agreement aims to provide workers and patients in healthcare with greater preventive measures against exposure to reprotoxic substances and hazardous medicinal products in the workplace.

This means that the Directive will be now known as the Carcinogens, Mutagens and Reprotoxic substances Directive (CMRD). 12 reprotoxins with a binding occupational  exposure limit will be introduced in Annex III to the Directive and included in the scope for the first time.

Moreover, training for workers handling hazardous medical drugs is added in the legal text as well as the commitment to adopt EU guidelines by the end of 2022.

CPME is a member of the Stop Cancer at Work Campaign which started in October 2020.